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ORIGINAL ARTICLE
Cervical biomarkers as predictors of successful induction of labour by Foley
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Heidi Kruita , Oskari Heikinheimoa, Timo Sorsab,c, Juuso Juhilad, Jorma Paavonena and Leena Rahkonena
aDepartment of Obstetrics and Gynaecology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; bDepartment of Oral and
Maxillofacial Diseases, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; cDivision of Periodontology, Department of Dental
Medicine, Karolinska Institute, Huddinge, Sweden; dMedix Biochemica, Espoo, Finland
ABSTRACT
The prediction of successful labour induction is difficult, indicating a need for a biomarker test. Little is
known about the effect of Foley catheter (FC) induction on biochemical mediators in the cervix, such as
the insulin-like growth factor binding protein-1 (IGFBP-1), matrix metalloproteinases (MMP) and their
inhibitors (TIMP). We enrolled 35 nulliparous women with singleton pregnancies, intact amniotic mem-
branes and cephalic presentation 40 gestational weeks scheduled for labour induction by FC. Serial
cervical swab samples were collected at FC insertion and expulsion. The concentrations of IGFBP-1,
PhIGFBP-1, MMP-8, MMP-2, MMP-9, TIMP-1 and TIMP-2 were analysed. The IGFBP-1 and phIGFBP-1 con-
centrations increased during the FC-induced cervical ripening. In contrast, MMP-8 and MMP-9 concen-
trations decreased. However, these changes did not predict the outcome of the labour induction, thus
appearing not suitable for clinical use.
IMPACT STATEMENT
 What is already known on this subject? During cervical ripening, various constituents interact in
a complex network. Insulin-like growth factor binding protein-1 (IGFBP-1), matrix metalloproteinases
(MMP) and their tissue inhibitors (TIMP) appear to play a role in cervical ripening. The mechanism
of Foley catheter on cervical ripening consists of direct mechanical stretching of the cervix and
lower uterine segment, and the stimulation of local secretion of endogenous prostaglandins.
 What do the results of this study add? This study investigated the role of cervical biochemical
mediators during Foley catheter-induced cervical ripening, and their predictive value in a successful
labour induction and vaginal delivery. The IGFBP-1 and phosphorylated IGFBP-1 concentrations
increased, whereas MMP-8 and MMP-9 concentrations decreased during the Foley catheter-induced
cervical ripening in nulliparous women. However, these changes did not predict the outcome of
labour induction, thus appearing not suitable for clinical use.
 What are the implications of these findings for clinical practice and/or further research?
Prediction of a successful labour induction is difficult, indicating a need for a biomarker test. Future
studies with larger data are needed for investigating the role of these cervical biomarkers in suc-









Induction of labour (IOL) is a common obstetric procedure.
However, prediction of successful labour induction is difficult
on the basis of maternal characteristics, the Bishop score or
transvaginal ultrasonography of the cervix (Crane 2006).
During cervical ripening, various constituents, such as hyalur-
onic acid, cytokines and inflammatory mediators appear to
interact in a complex network (Aalberts et al. 2007). The
mechanism of Foley catheter (FC) on cervical ripening con-
sists of direct mechanical stretching of the cervix and lower
uterine segment combined with the stimulation of local
secretion of endogenous prostaglandins (Manabe et al. 1982).
Little is known of the effect of FC on the biochemical media-
tors in the cervix.
Insulin-like growth factor binding protein-1 (IGFBP-1), syn-
thesised by the foetal and maternal liver and decidua,
increases during pregnancy (Rutanen et al. 1982). The non-
phosphorylated isoform of IGFBP-1 is a major protein in the
amniotic fluid from the second trimester onwards, while the
decidual cells secrete predominantly the phosphorylated iso-
forms (phIGFBP-1) (Westwood et al. 1994). The concentration
of phIGFBP-1 reflects cervical ripeness and increases during
the cervical ripening with prostaglandins (Nuutila et al. 1999).
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Matrix metalloproteinases (MMPs) are genetically distinct
but are structurally related endopeptidases with many func-
tions, including the remodelling and degradation of the
extracellular matrix and non-matrix bioactive substrates
(Weiss et al. 2007). The proteolytic activity of MMPs is inhib-
ited by the tissue inhibitors of metalloproteinases (TIMPs)
(Brew and Nagase 2010). Several MMPs (-1, -2, -3, -7, -8
and -9) and TIMP-1 and -2 are found in the foetal membranes
during gestation (Weiss et al. 2007). MMPs are important
mediators in the pathological processes resulting in preterm
labour but they also appear to play a role in the initiation of
labour at term. Especially MMP-8, -9, and TIMP-1 and -2 seem
to be involved in cervical ripening (Sennstrom et al. 2003;
Heng et al. 2012).
The aim of the study was to evaluate changes in cervical
biochemical mediators IGFBP-1, phIGFBP-1, MMPs-2, -8, -9,
TIMP-1 and -2 during FC-induced cervical ripening in nullipar-
ous women. We also wanted to analyse these biomarkers in
relation to the outcome of labour induction.
Materials and methods
This prospective study was conducted at the Department of
Obstetrics and Gynaecology of Helsinki University Hospital
between September 2014 and June 2015. The study protocol
was approved by the Helsinki and Uusimaa Hospital District
ethic committee (Nr. 268/13/03/03/2012). The approval to
carry out the study was granted by the Hospital district of
Helsinki and Uusimaa (§41/17.10.2012). Written informed con-
sent was obtained from all women.
Participants
We enrolled pregnant nulliparous women with gestational
age of 40þ0 weeks, cephalic presentation, intact amniotic
membranes, obstetric indication for IOL, reassuring foetal car-
diotocography and an unripe cervix with a Bishop Score <6
(Bishop 1964) at the time of admission. The duration of preg-
nancy was defined by the foetal crown-rump length measure-
ment performed at the time of the first trimester ultrasound
screening. Women with hypertensive disorders, pre-eclampsia,
foetal growth restriction, vaginal bleeding, any symptom or
sign of infection, HIV and hepatitis-B or -C were excluded
from the study. None of the participants had regular contrac-
tions or any evidence of rupture of membranes at the time
of enrolment. The same physician (HK) examined all women,
collected all samples and managed the FC procedure.
Cervical samples
Before insertion of the FC, four swab samples were collected
by inserting a sterile swab into the cervical canal and rotating
it for 15 s during speculum examination. The swabs were
then each swirled in their respective extraction solution for
15 s. The sample solutions were frozen and stored at 20 C
until the analysis of IGFBP-1, phIGFBP-1, MMP-2, MMP-8,
MMP-9, TIMP-1 and TIMP-2 concentrations. After expulsion of
the FC, four serial swab samples were again collected as
described earlier. The samples were obtained by the same
obstetrician with a maximum delay of 10min before insertion
and after expulsion of the FC. All samples were analysed in
the same laboratory (Medix Biochemica, Espoo, Finland),
which was blinded to the clinical status and the outcome of
labour induction.
Analysis of IGFBP-1 and phIGFBP-1 by
immunoenzymometric assays
The concentrations of cervical IGFBP-1 and phIGFBP-1 were
measured by two immunoenzymometric assays using
monoclonal antibodies (Medix Biochemica, Espoo, Finland).
The IGFBP-1 assay employing monoclonal antibody 6305
detects the non-phosphorylated and less phosphorylated
isoforms of IGFBP-1, while phIGFBP-1 assay employing
monoclonal antibody 6303 recognises the highly phos-
phorylated forms (Nuutila et al. 1999). The detection limit
of both the assays was 0.3mg/L. All samples were meas-
ured in duplicates.
Analysis of MMP-8 by immunoenzymometric assay
MMP-8 was quantitated with a solid-phase immunoenzymo-
metric assay (MMP-8 IEMA, Medix Biochemica, Espoo, Finland)
(Nieminen et al. 2015). This sandwich assay uses two mono-
clonal antibodies against human MMP-8. Microplate wells
were coated with one monoclonal antibody against MMP-8.
The other antibody was conjugated to HRP forming the
enzyme conjugate used to detect the presence of MMP-8.
The analyses were performed according to the manufacturer’s
instructions, and the absorbance of the solutions in the wells
was measured at 414 nm using a microplate reader
(Multiskan, Thermo Fisher Scientific, Vantaa, Finland).
Analysis of MMP-2, -9, TIMP-1 and -2 by ELISA
MMP-2 and MMP-9 analyses were carried out by using com-
mercially available ELISA kits (Biotrak ELISA Systems; GE
Healthcare Life Sciences for MMP-2 and TIMP-1, and
Quantikine ELISA Kit; R and D Systems for MMP-9 and TIMP-2)
according to the manufacturer’s instructions. The balance
between the quantities of MMP-8 and TIMP-1 was roughly
estimated from our data on the basis of the molar ratio.
Foley catheter insertion
A single balloon catheter (R€usch 2-way Foley, Couvelaire tip,
catheter size 22 Ch, Teleflex Medical, Athlone, Ireland) was
introduced through the endocervix during speculum examin-
ation. The balloon was inflated with 50mL of saline, a light
traction was applied so that the balloon rested on the
internal os, and the catheter was taped to the inner thigh.
A transvaginal ultrasound was performed to assure balloon
placement. The status was monitored every two hours for
vaginal expulsion, and light traction was reapplied if neces-
sary. After a spontaneous expulsion of the balloon, amniot-
omy was performed if the Bishop score was 6, and the
928 H. KRUIT ET AL.
induction was continued with oxytocin if spontaneous con-
tractions did not occur. If the Bishop score remained <6 after
the balloon expulsion, cervical ripening was continued
according to the hospital management guidelines, using
misoprostol 25 mg vaginally or 50 mg orally every 4 h until the
Bishop score was 6.
Outcomes
The data on the study population characteristics and out-
comes were obtained from the hospital records. Labour arrest
in the first stage of labour was defined as a failure to pro-
gress despite ruptured membranes and a minimum of 4 h of
adequate uterine activity without a cervical change (Caughey
et al. 2014). A failed induction was diagnosed after ruptured
membranes and 12 h of oxytocin administration without a
cervical change (Caughey et al. 2014). The induction-to-
delivery interval was defined as the time from insertion of
the FC to delivery.
Statistical analysis
All calculations were carried out using the Microsoft
Statistical Package for Social Sciences (SPSS Inc., Chicago, IL)
for Windows v18.0. Categorical variables were compared with
a Chi-square test and Fisher’s exact test when appropriate.
The continuous variables were assessed with a T-test when
the data was normally distributed, and with a Mann–Whitney
U test if the data did not follow a normal distribution. The
correlations between the cervical biomarker concentrations
(at FC insertion, at FC expulsion, and the change in concen-
tration) and the labour outcomes were analysed using
Pearson’s correlation coefficient. A p value of < .05 was con-
sidered as significant.
Results
A total of 35 nulliparous women were enrolled. One woman
was excluded due to the rupture of membranes after inser-
tion of the FC. The characteristics and obstetric outcomes of
the study population are shown in Table 1. Half of the
women (n¼ 17) had Bishop Score 3 at the start of IOL
(Table 1). The main indication for IOL was post-term preg-
nancy (79.4%) (Table 1). The mean (SD) time from FC inser-
tion to expulsion was 255 (±169) minutes, with the range of
1.5–18.2 h. The mean (SD) induction-to-delivery interval was
1681 (±802) min.
Table 2 shows the baseline concentrations of the cervical
biomarkers. The median IGFBP-1 and phIGFBP-1 concentra-
tions increased (from 1.8 to 23.5mg/L; p¼ .008 and from 5.5
to 75.5mg/L; p¼ .001, respectively), and the MMP-8 and
MMP-9 concentrations decreased (from 446.0 to 230.0 mg/L;
p< .001 and from 431.5 to 178.4 mg/L; p< .001, respectively)
during the FC-induced cervical ripening (Figures 1 and 2).
The mean MMP-2 concentration at the start of IOL was low
and did not change (Figure 2). The concentrations of TIMP-1
did not significantly change, whereas the concentrations of
TIMP-2 decreased (from 9.3 to 5.6 mg/L; p¼ .02) during the FC
ripening (Figure 3).
Of the cervical biomarkers, only MMP-8 differed between
the women with Bishop Scores of 3 and >3 at the start of
IOL (593.0 [41–1998] vs. 408 [28–1335] mg/L [median [range]];
p¼ .02). Also, the concentration of MMP-8 decreased more in
the women with a Bishop score <3, compared with the
Table 1. Patient characteristics and obstetric outcomes.
n¼ 34 N %
Maternal age [mean (SD)] 31.2 (±4.4)
BMI (kg/m2) [mean (SD)] 24.5 (±4.6)
BMI (kg/m2) 30 kg/m2 5 14.7
Smoking 1 2.9
Gestational diabetes 9 26.5
Bishop 3 at start IOL 17 50.0
Post-term pregnancy (42 weeks) 27 79.4
Indication for IOL
Post-term pregnancy 27 79.4
Othera 7 20.6
Bishop score 6 at FC expulsion 28 82.4
Subsequential misoprostol use 6 17.6
Oxytocin use 32 94.1
Oxytocin use for induction of labour 18 52.9
Caesarean delivery 15 44.1
Foetal distress 2 13.3
Labour arrest 6 40.0
Failed induction 5 33.3
Otherb 2 13.4
Vaginal delivery within 24 h 10 29.4
BMI: body mass index; IOL: induction of labour; FC: Foley catheter.
aCholestasis of pregnancy n¼ 2, gestational diabetes n¼ 2, foetal macrosomia
n¼ 2, psychosocial reasons n¼ 1.
bUmbilical cord prolapse n¼ 1, maternal epileptic seizure n¼ 1.
Table 2. The baseline concentrations (mg/l) of the cervical biomarkers prior to
Fc insertion.
Cervical biomarker Median (range) Interquartile range
IGFBP-1 2 (0.1–261) 0.6–26
phIGFBP-1 6 (0.3–976) 2–62
MMP-2 9 (1–39) 5–18
MMP-8 446 (28–1998) 260–1340
MMP-9 433 (11–3019) 233–832
TIMP-1 16 (1–162) 7–31
TIMP-2 26 (1–111) 6–41
Figure 1. Cervical IGFBP-1 and phIGFBP-1 concentrations increase during Foley
catheter cervical ripening.
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women having Bishop score of 4–6 (443.0 [346–1834] vs.
209.0 [293–1001] mg/L [median [range]]; p¼ .01). The six
(17.6%) women whose Bishop score remained <6 after an FC
expulsion had similar biomarker concentrations compared to
the 28 women with a successful FC ripening.
The median (range) concentrations of IGFBP-1 and
phIGFBP-1 increased more in women who started having
spontaneous contractions compared to the women who
needed oxytocin induction (15.4 [61.0 to 716.7] vs. 9.5
[195.0 to 70.7] mg/L; p¼ .02 for IGFBp-1 and 30.8 [162.0 to
1527.1] vs. 24.5 [843.0 to 187.0] mg/L; p¼ .05). When com-
paring the mode of delivery, no significant differences in the
baseline concentrations of the cervical biomarkers were
observed between the women with a vaginal delivery and
the women who delivered by caesarean section due to a fail-
ure to progress (Table 3).
Discussion
Our results suggest that IGFBP-1, phIGFBP-1, MMP-8, MMP-9
and TIMP-2 are involved in the process of cervical ripening
induced by FC. We studied only nulliparous women, since the
concentrations of phIGFBP-1 and MMP-8 differ between nul-
liparous and multiparous women (Rahkonen et al. 2009a,
2009b). Almost 80% of the women were post-term with half
of the women having Bishop score 3 at the start of IOL.
The CS rate in our study was high, but similar rates in post-
term nulliparous women with an unfavourable cervix have
been reported by several previous studies (Frederiks et al.
2012; Marroquin et al. 2013; Kruit et al. 2015). A recent study
suggested that cell-free foetal DNA may initiate the process
of cervical ripening and labour (Phillippe 2014). However, the
exact mechanism and biochemical mediators are yet to be
uncovered. Cervical ripening is characterised by a leucocyte
infiltration and the remodelling of extracellular matrix pro-
teins, such as collagen (Riskin-Mashiah and Wilkins 1999).
A study of cervical mucus plugs in 17 women during active
labour reported a large quantity of MMP-2, MMP-8, MMP-9,
and their inhibitors TIMP-1 and TIMP-2 in the cervical mucus
(Becher et al. 2004). The proteolytic or non-proteolytic effects
of MMPs and TIMPs in the cervical mucus may include a deg-
radation of local extracellular matrix components thereby
enhancing a cervical softening and affecting the overlying
cervical membranes. Hyaluronic acid in the extracellular
matrix may also play a role, resulting in cervical softening
and swelling (Hascall et al. 2004). The mechanism of Foley
catheter on cervical ripening constitutes direct mechanical
stretching of the cervix and lower uterine segment, and
stimulation of endogenous prostaglandin release by stripping
the foetal membranes (Manabe et al. 1982; Keirse et al. 1983).
Mechanically stretching the cervix during parturition has also
been shown to augment the production of hyaluronic acid in
uterine cervical fibroblast cells (Takemura et al. 2005).
Nuutila et al. (1999) found a higher IGFBP-1 concentrations
in women with a ripe cervix (Bishop Score>6) compared
with women having an unripe cervix. In our study, only
women with an unripe cervix were included. The study by
Nuutila et al. (1999) also demonstrated an increase in cervical
IGFBP-1 concentration after application of prostaglandin E2
gel for cervical ripening. A similar increase in cervical IGFBP-1
and phIGFBP-1 following cervical ripening by FC was seen in
our study. However, the cervical IGFBP-1 concentrations did
not predict induction to delivery interval, as also seen in the
previous study (Nuutila et al. 1999). In a recent study by
Kosinska-Kaczynska et al. (2015), the presence of cervical
phIGFBP-1 predicted spontaneous onset of labour and
Figure 2. Cervical MMP-8 and MMP-9 concentrations decrease during Foley
catheter cervical ripening. MMP-2 concentration does not significantly change.
Figure 3. Cervical TIMP-1 concentration does not significantly change, whereas
TIMP-2 concentration decreases during Foley catheter cervical ripening.






CS for failure to
progress (n¼ 11) p value
IGFBP 2 (0.1–158) 2 (0.7–261) .67
pHIGFBP 4 (0.3–277) 19 (0.8–976) .67
MMP-2 9 (1–39) 18 (3–21) .97
MMP-8 446 (28–1998) 446 (138–1990) .64
MMP-9 505 (11–3019) 334 (59–2252) .74
TIMP-1 12 (1–83) 159 (3–162) .58
TIMP-2 27 (0.7–111) 39 (5–44) 1.00
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successful vaginal delivery in term and post-term pregnan-
cies. This was not seen in our study, since the IGFBP-1 and
phIGFBP-1 concentrations did not differ between women
who delivered vaginally and those who delivered by caesar-
ean section due to failure to progress. In Kosinska-
Kaczynska’s study, women with the positive phIGFBP-1 test
also developed regular uterine contractions earlier after cer-
vical ripening (Kosinska-Kaczynska et al. 2015). A similar trend
was also seen in our study, in which the IGFBP-1 and
phIGFBP-1 increased more in women who started having
spontaneous contractions following the FC ripening.
The concentrations of MMP-8 and MMP-9 are higher in
term women with labour compared with women not in
labour (Dubicke et al. 2008). A recent study of 18 cervical
samples, collected by an extra-amniotic irrigation or cervical
biopsy, concluded that FC may induce cervical ripening
through changes in biochemical mediators (Lim et al. 2013).
MMP-8 expression was higher in the women with a spontan-
eous onset of labour, and after expulsion of FC, when com-
pared with the non-pregnant women or the women before
FC insertion at term (Lim et al. 2013). Also, the concentrations
of MMP-8 increased over time during the FC ripening (Lim
et al. 2013). However, the sample size was smaller and their
sampling method differed from ours. In contrast, in our study
the MMP-8 concentration decreased during the FC-induced
ripening. Surprisingly, MMP-8 concentration was higher in
women with less ripe (Bishop Score 3) cervices at start of
IOL, and the decrease was greater during cervical ripening.
MMP-8 and MMP-9 deficient mouse models and human stud-
ies have revealed that physiological MMP-8 and -9 levels,
modifying extracellular matrix and immune responses, have
destructive and defensive effects (Sorsa et al. 2006; Saarinen
et al. 2016). The decreased MMP-8 and -9 concentrations
recorded here may reflect a reduced defensive potential asso-
ciated with a labour induction by FC.
The activities of the metalloproteinases are highly depend-
ent on the interaction and balance with the TIMPs. TIMP-1
and TIMP-2 significantly increase in spontaneous labour
(Heng et al. 2012). An increase of TIMP-1 concentrations in
cervical tissue with progressive cervical dilatation (from 2 cm
to 6 cm) during labour has previously been observed (Winkler
and Rath 1999). In our study, the TIMP-1 concentrations were
low and did not significantly change during the FC ripening,
whereas the TIMP-2 concentrations decreased. This may
reflect the homeostatic regulation of extracellular matrix
remodelling by TIMP-1 and TIMP-2 (Heng et al. 2012).
Nevertheless, TIMPs exert growth-factor-like properties inde-
pendent of an MMP-inhibition (Chirco et al. 2006; Stetler-
Stevenson 2008).
The major limitations of the study are the relatively small
number of patients and the lack of power analysis. Also, there
may have been inter-individual biological variation reflected
in the cervical concentrations of IGFBP-1, phIGFBP-1, MMPs
and TIMPs, differences in the bacterial flora of the upper
vagina, and differences of cellularity of the cervical mucus.
Although samples were collected by the same person, there
may have been variation in extraction from the swab into the
sample buffer which may have influenced the concentrations.
Another weakness of the study are the ACOG definitions
used for failed induction and labour arrest in the first stage
of labour. These definitions were accurate during the research
undertaken, but are no longer up-to-date. The main strength
of this study is the well-defined patient group with a uniform
dating of pregnancy by the first trimester ultrasound. Also,
the sampling technique, determination of cervical status, and
management of the FC cervical ripening were standardised
and performed by the same obstetrician.
In conclusion, the data indicates an increase in the IGFBP-1
and phIGFBP-1 concentrations, and a decrease in MMP-8,
MMP-9 and TIMP-2 concentrations in the cervix during an FC-
induced ripening in nulliparous women. However, these
cervical biomarkers appear not suitable for clinical use in
predicting the outcome of labour induction.
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